Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B, Chronic

Explore clinical trials studying Hepatitis B, Chronic. Study availability and eligibility vary by location and protocol.

532 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B, Chronic trial results

Completed

Study of Safety and Tolerability of DCR HBVS

NCT03772249

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Monash Health Clayton, Victoria, Australia
  • St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia
  • Queen Mary Hospital (The University of Hong Kong) Hong Kong
  • Clinical Site Auckland, New Zealand
View Trial Details
Completed

Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection

NCT06544551

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
Locations
  • Beijing Ditan Hospital, Capital Medical University Beijing, China
  • Beijing Youan Hospital, Capital Medical University Beijing, China
  • Peking university Peoole's hospital Beijing, China
  • The First Hospital of Jilin University Changchun, China
View all 34 locations
View Trial Details
Completed

A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

NCT04667104

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Tokyo Medical and Dental University Hospital Bunkyō City, Japan
  • Osaka University Hospital Suita-shi, Japan
  • New Zealand Clinical Research Auckland, New Zealand
  • Middlemore Clinical Trials Papatoetoe, New Zealand
View Trial Details
Completed

Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)

NCT04676724

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Iowa City, Iowa, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site New York, United States
View all 49 locations
View Trial Details

Related conditions